Live Breaking News & Updates on Covishield Astrazeneca|Page 2

Stay updated with breaking news from Covishield astrazeneca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cureus | Coverage of Coronavirus Disease-2019 (COVID-19) Booster Dose (Precautionary) in the Adult Population: An Online Survey

Background

The coronavirus disease-2019 (COVID-19) pandemic devastated public health worldwide, including India. COVID-19 vaccines and their boosters are life-saving developments that have helped prevent and control the spread of COVID-19. We conducted this study to assess the coverage of the booster dose in an Indian population (the third dose of the COVID-19 vaccine in India is referred to as the booster or precautionary dose), record the reasons for not taking the booster dose, and determine the effectiveness of the booster. The levels of adherence to COVID-19 precautionary behavior was also assessed. 

Methods

We conducted a descriptive, cross-sectional study using convenient sampling via an online survey of 550 respondents older than 18 in the second quarter of 2022. The respondents were distributed among 18 states and union territories in India. The data were analyzed as simple proportions and percentages.

Results

Of the 550 respondent ....

United States , Uttar Pradesh , Madhya Pradesh , Andhra Pradesh , Himachal Pradesh , Tamil Nadu , Covishield Astrazeneca , Anagha Brahmajosyula , Covishield Oxford Astrazeneca , Namita Acharya , Aniket Khamar , Lavanya Bilichod , Deepika Kondath , World Health Organization , Nursing Allied Health Sciences Dentistry , Vaccine Intelligence Network , Covaxin Bharat Biotech International Ltd , Kempegowda Institute Of Medical Sciences , Serum Institute Of India Private Ltd , Behavior Change Communication , Serum Institute , India Private Ltd , Bharat Biotech International Ltd , Google Forms , Mountain View , Institutional Ethics Committee ,